The detailed information for PTAB case with proceeding number IPR2020-00193 filed by Amneal Pharmaceuticals LLC et al. against Cubist Pharmaceuticals LLC et al. on Nov 27, 2019. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2020-00193
Filing Date
Nov 27, 2019
Petitioner
Amneal Pharmaceuticals LLC et al.
Respondent
Cubist Pharmaceuticals LLC et al.
Status
Institution Denied
Respondent Application Number
14096346
Respondent Tech Center
1600
Respondent Patent Number
9138456
Institution Decision Date
May 29, 2020

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Trial Instituted Document

May 29, 2020PAPERBOARD

Lyophilization and Development of Solid Protein Pharmaceuticals

Mar 6, 2020EXHIBITPATENT OWNER

Patent Trial and Appeal Board Consolidated Trial Practice Guide

Mar 6, 2020EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

Mar 6, 2020PAPERPATENT OWNER

Annex 1 to EMA authorization of Cubicin¿¿

Mar 6, 2020EXHIBITPATENT OWNER

Glass Transition and Crystallization of Amorphous Trehalose-sucrose Mixtures

Mar 6, 2020EXHIBITPATENT OWNER

Differential Scanning Calorimetry Study of Phase Transitions Affecting the Quality of Dehydrated Materials

Mar 6, 2020EXHIBITPATENT OWNER

Determination of the Glass Properties of D-Mannitol Using Sorbitol as an Impurity

Mar 6, 2020EXHIBITPATENT OWNER

PATENT OWNER'S MANDATORY NOTICES

Dec 18, 2019PAPERPATENT OWNER

POWER OF ATTORNEY

Dec 18, 2019PAPERPATENT OWNER

Notice of Accord Filing Date

Dec 6, 2019PAPERBOARD

Petitioner's Power of Attorney

Nov 27, 2019PAPERPETITIONER

Prosecution history of US Patent No. 9,138,456 B2

Nov 27, 2019EXHIBITPETITIONER

US Patent No. 7,112,565 B2 (¿¿¿Sawai¿¿¿)

Nov 27, 2019EXHIBITPETITIONER

Physicians¿¿¿ Desk Reference, 60th ed., pp. 1038-1042 (2006)

Nov 27, 2019EXHIBITPETITIONER

US Patent No. 9,138,456 B2

Nov 27, 2019EXHIBITPETITIONER

Declaration of Dr. Raj Suryanarayanan

Nov 27, 2019EXHIBITPETITIONER

Cubicin Label

Nov 27, 2019EXHIBITPETITIONER

US Patent No. 6,136,783 (¿¿¿Neururkar¿¿¿)

Nov 27, 2019EXHIBITPETITIONER

Patent Application Publication No. 2010/0137197 A1 ("Mittal")

Nov 27, 2019EXHIBITPETITIONER

EU Application Publication No. EP 0 386 951 A2 ("Inman")

Nov 27, 2019EXHIBITPETITIONER

US Patent No. 8,835,382 B2

Nov 27, 2019EXHIBITPETITIONER

Cancidas (Caspofungin) label

Nov 27, 2019EXHIBITPETITIONER

¿¿¿Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice¿¿¿

Nov 27, 2019EXHIBITPETITIONER

¿¿¿Extending Shelf Like Just Makes Sense¿¿¿

Nov 27, 2019EXHIBITPETITIONER

EU Patent Application Publication No. EP 2 918 324 A1

Nov 27, 2019EXHIBITPETITIONER

European Medicines Agency, Caspofungin Accord: European Public Assessment Report (2015)

Nov 27, 2019EXHIBITPETITIONER

European Medicines Agency, Cubicin: European Public Assessment Report ¿¿¿ Scientific Discussion (2006)

Nov 27, 2019EXHIBITPETITIONER

Petition for Inter Partes Review

Nov 27, 2019PAPERPETITIONER